ArticleGenetics2026
Transposon regulation in the Caenorhabditis elegans germline and soma.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tissue-specific DNA repair strategies underlie apparent high transposon activity in the Caenorhabditis elegans soma.G3 (Bethesda, Md.) · 2026Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Transposons are parasitic nucleic acids present in most genomes. The ability of transposons to mobilize makes them a source of genetic diversity and a threat to genome integrity. Interestingly, mutations in the Caenorhabditis elegans gene rde-3 increase the rate of transposition in the germline, but not in the soma, suggesting that the C. elegans germline and soma employ different strategies to regulate Tc1 transposition. Here, we develop fluorescence reporters for studying DNA transposon regulation in living C. elegans in a tissue-specific manner, and we use candidate gene testing and genetic screening approaches to identify factors that regulate Tc1 mobility in the germline and/or the soma of the animal. We find that both cytoplasmic and nuclear components of the RNA interference (RNAi) pathway silence Tc1 in the germline, but not in the soma. We identify a novel pathway involving the C. elegans ortholog of heterogeneous nuclear ribonucleoprotein C (HNRNPC) and a gene we term suppressor of transposon mobilization (stm)-1, which regulates Tc1 primarily in the soma, likely by binding Tc1 RNA and preventing its splicing. Our findings reveal tissue-specific strategies for regulating parasitic nucleic acids and pave the way for future studies exploring how and why different tissues adopt different transposon silencing systems.
Indexed as
Identifiers
41875389What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.